Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects

NCT01922336 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: SB2
BIOLOGICAL: EU Remicade
BIOLOGICAL: US Remicade

Sponsor

Samsung Bioepis Co., Ltd.